Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Medical University of South Carolina
Medical College of Wisconsin
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of California, San Diego
Dana-Farber Cancer Institute
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
University of Utah
Mayo Clinic
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Vitebsk Regional Clinical Cancer Centre
University Hospital Heidelberg
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
OHSU Knight Cancer Institute
Jewish General Hospital
Dana-Farber Cancer Institute
Columbia University
Fred Hutchinson Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Shenzhen Institute for Innovation and Translational Medicine
Karolinska University Hospital
Chinese PLA General Hospital
Mayo Clinic
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Mayo Clinic
University of California, San Diego
German CLL Study Group
Chinese PLA General Hospital
Scripps Health
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
Memorial Sloan Kettering Cancer Center